Clinical Trials

Showing trials with last updates posted in 2023.

NCT02561273 | COMPLETED | PHASE1/PHASE2
54 participants

Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2023-12-13
Start Date:
2015-09-28
Completion:
2019-11-01
Conditions
  • Anaplastic Large Cell Lymphoma, ALK-Negative
  • Anaplastic Large Cell Lymphoma, ALK-Positive
  • Hepatosplenic T-Cell Lymphoma
  • Peripheral T-Cell Lymphoma, Not Otherwise Specified
  • Stage II Angioimmunoblastic T-cell Lymphoma
  • Stage II Enteropathy-Associated T-Cell Lymphoma
  • Stage III Angioimmunoblastic T-cell Lymphoma
  • Stage III Enteropathy-Associated T-Cell Lymphoma
  • Stage IV Angioimmunoblastic T-cell Lymphoma
  • Stage IV Enteropathy-Associated T-Cell Lymphoma
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
NCT06167356 | RECRUITING
20000 participants

Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.

Study Type:
OBSERVATIONAL
Last Updated:
2023-12-12
Start Date:
2013-11-27
Completion:
2063-11-27
Conditions
  • Non Muscle Invasive Bladder Cancer
  • Non-Muscle Invasive Bladder Neoplasms
  • Non-Muscle Invasive Bladder Urothelial Carcinoma
  • Bladder Cancer
  • Bladder Disease
  • Bladder Neoplasm
  • Bladder Urothelial Carcinoma
  • Bladder Cancer Stage I, With Cancer in Situ
  • Bladder Cancer Recurrent
  • Bladder Urothelial Carcinoma in Situ
  • Bladder Urothelial Dysplasia
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page